Jeanne Bolger

Venture Partner at Seroba Life Sciences

View Live Interactive Profile →

Biography

Jeanne Bolger is a Venture Partner at Seroba with over 35 years of pharmaceutical industry experience across R&D, commercial, business development and venture investment. She spent 11 years in licensing and acquisition, including as Global Head of Scientific Licensing for Johnson & Johnson's pharmaceutical business and as a Director in business development at GlaxoSmithKline. From 2012 to 2022 she was Vice President Venture Investment at JJDC in London, leading European early-stage life science investments and representing JJDC on the boards of more than a dozen companies. She chairs the boards of Exevir, Astrivax and Sapreme and is a non-executive director of Life Healthcare Group Holdings.

Education

Previous Experience

Notable Investments

Aelix TherapeuticsAsceneuron SAAviado BioBiocartisCalypso BiotechInivataMerusPulmocideS-BiomedicSyndesiT-Rex

Board Seats

Career Timeline

2012
Became Vice President Venture Investment at Johnson & Johnson Innovation – JJDC, based in London.
2022
Concluded nearly ten years at JJDC.

Sources & References

Seroba - Team ↗